Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × cabozantinib × 90 days × Clear all

Phase

Phase 2 31 Phase 3 12 Phase 1 11 Phase 1/2 7 Phase 2/3 1

Sponsor

Interventions

pembrolizumab 10 Specimen Handling 9 Magnetic Resonance Spectroscopy 9 Biopsy 8 Cyclophosphamide 7 Nivolumab 6 fludarabine 5 Radiotherapy 4 Immunotherapy, Adoptive 4 Cisplatin 4 tremelimumab 3 encorafenib 3 X-Rays 3 Tirzepatide 3 Temozolomide 3 Surgical Procedures, Operative 3 Standard of Care 3 Rituximab 3 Radiosurgery 3 Paclitaxel 3 Immune Checkpoint Inhibitors 3 Folfox protocol 3 Carboplatin 3 Bevacizumab 3 Aspirin 3 venetoclax 2 perflutren 2 olaparib 2 niraparib 2 lenvatinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡